FDA says "wait" to dying men.

We arrived at the FDA visitor parking lot at 7:45 AM ready to protest at 8:00. There were already many visitors parked there and the FDA lot was already full of cars. We walked across the street so we were right in front of the 5600 Fischer, the FDA Parklawn building.

FDA has started to look into the additional side effects of Merck's Singulair drug for Asthma treatment as reports link suicidal thoughts to Singulair.

Anemia drugs made by Amgen and Johnson & Johnson may raise the risk of death among those suffering from cancerous diseases, a new study says.

A drug related to the class of proton pump inhibitors, most effective in reducing gastric acid secretion, was approved for the use in children.

A mere mistake in records may lead to unexpected things. For example, the Food and Drug Administration's Center for Drug Evaluation and Research mistakenly cleared the heparin facility belonging to another company with a similar name.

At least one critic of the US Food and Drug Administration (FDA) says the organization acted too slowly when it learned of the dangers of Trasylol. According to Dr. Dennis Mangano, approximately 22,000 lives could have been saved if the FDA had removed Trasylol from the market when it received evidence that the drug was linked to thousands of deaths. The FDA received that information two years ago from Dr. Mangano.

A poor man's lobbying effort.

The FDA recalled Tuesday all the patches (25-microgram-per-hour patches with expiration dates on or before December 2009) containing fentanyl, because it can have a serious defect.

FDA, the Federal Drug Administration, has launched a study to review chemicals used in tattoo parlors. The US government initiated the research against the background of numerous incidents of skin problems, which particularly include rashes, blistering and swelling. The chemicals are used for tattoos which can be seen on various body parts of about 45 million American citizens.

Open letter to Chairman Dingell and Ranking Member Barton, Subcommittee Chairman Pallone and Ranking Member Deal, and Chairman Stupak and Ranking Member Shimkus:

Food and Drug Administration fined the Red Cross $4.6 million after the latter did not make it to test blood donations and questioning donors.